L

Lepu Biopharma Co Ltd
HKEX:2157

Watchlist Manager
Lepu Biopharma Co Ltd
HKEX:2157
Watchlist
Price: 5.43 HKD 5.23% Market Closed
Market Cap: 9.8B HKD

Intrinsic Value

The intrinsic value of one Lepu Biopharma Co Ltd stock under the Base Case scenario is 7.59 HKD. Compared to the current market price of 5.43 HKD, Lepu Biopharma Co Ltd is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
7.59 HKD
Undervaluation 29%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Lepu Biopharma Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Lepu Biopharma Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Lepu Biopharma Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lepu Biopharma Co Ltd.

Explain Valuation
Compare Lepu Biopharma Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Lepu Biopharma Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Lepu Biopharma Co Ltd

Balance Sheet Decomposition
Lepu Biopharma Co Ltd

Current Assets 704.5m
Cash & Short-Term Investments 536.3m
Receivables 121.3m
Other Current Assets 46.8m
Non-Current Assets 1.7B
Long-Term Investments 108.4m
PP&E 1.1B
Intangibles 462.6m
Other Non-Current Assets 34m
Current Liabilities 1.1B
Accounts Payable 226.2m
Other Current Liabilities 885.6m
Non-Current Liabilities 504.6m
Long-Term Debt 244.2m
Other Non-Current Liabilities 260.4m
Efficiency

Free Cash Flow Analysis
Lepu Biopharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lepu Biopharma Co Ltd

Revenue
700.5m CNY
Cost of Revenue
-81.2m CNY
Gross Profit
619.3m CNY
Operating Expenses
-784m CNY
Operating Income
-164.7m CNY
Other Expenses
-12.5m CNY
Net Income
-177.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Lepu Biopharma Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
24/100
Profitability
Score

Lepu Biopharma Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Lepu Biopharma Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Average Altman Z-Score
45/100
Solvency
Score

Lepu Biopharma Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Lepu Biopharma Co Ltd

Wall Street analysts forecast Lepu Biopharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lepu Biopharma Co Ltd is 10.59 HKD with a low forecast of 10.48 HKD and a high forecast of 10.9 HKD.

Lowest
Price Target
10.48 HKD
93% Upside
Average
Price Target
10.59 HKD
95% Upside
Highest
Price Target
10.9 HKD
101% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lepu Biopharma Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Lepu Biopharma Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Lepu Biopharma Co Ltd stock?

The intrinsic value of one Lepu Biopharma Co Ltd stock under the Base Case scenario is 7.59 HKD.

Is Lepu Biopharma Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5.43 HKD, Lepu Biopharma Co Ltd is Undervalued by 29%.

Back to Top